Skip to main content

Ciclosporin for Therapy of Severe Aplastic Anemia (SAA) and Pure Red Cell Aplasia (PRCA)

  • Conference paper

Abstract

In severe aplastic anemia (SAA) there are several experimental and clinical observations which prompted us to test the efficacy of ciclosporin (CyA). Among them are laboratory observations which underline the autoimmune pathogenesis of SAA:(a) the prevention of CFU-GM suppressor T cells by in vitro preincubation with CyA of SAA T lymphocytes [5], and (b) the suppressive effect of CyA on the production of gamma interferon, a lymphokine recently designated as the in vivo soluble mediator of aplastic anemia [7, 8]. Clinically, in the field of bone marrow transplantation for SAA, a reduced occurrence of allograft failure with the use of CyA as prophylaxis of graft-versus-host disease was another important argument for the use of CyA [4].

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Camilla BM, Storb R, Thomas ED (1982) Aplastic anemia (second of two parts). Pathogenis, diagnosis, treatment, and prognosis. N Engl J Med 306:712–718

    Article  Google Scholar 

  2. Clark DA, Dessypris EN, Krantz SB (1984) Studies on pure red cell aplasia. XI. Results of immunosuppressive treatment of 37 patients. Blood 63:277–286

    PubMed  CAS  Google Scholar 

  3. Debusscher L, Paridaens R, Stryckmans P, Delwiche F (1985) Cyclosporine for pure red cell aplasia. Blood 65:249

    PubMed  CAS  Google Scholar 

  4. Hows JM, Palmer S, Gordon-Smith EC (1982) Use of cyclosporin A in allogeneic bone marrow transplantation for severe aplastic anemia. Transplantation 33:382–386

    Article  PubMed  CAS  Google Scholar 

  5. Podesta M, Bacigalupo A, Frassoni F, Raffo M, Piagigo G, Repetto M, van Lint M, Marmont A (1983) Generation of CFU-C suppressor T cells. VI. Effects of Cyclosporin A. Acta Haematol 70:163–169

    Article  PubMed  CAS  Google Scholar 

  6. Stryckmans PA, Dumont JP, Velu TH, Debusscher L (1984) Cyclosporine in refractory severe aplastic anemia. N Eng J Med 310:656–657

    Article  Google Scholar 

  7. Zoumbos N, Djeu J, Young N (1984) Interferon is the suppressor of hematopoiesis generated by stimulated lymphocytes in vitro. J Immunol 133:769–774

    PubMed  CAS  Google Scholar 

  8. Zoumbos NC, Gascon P, Djeu JY, Trost SR, Young NS (1985) Circulating activated suppressor T lymphocytes in aplastic anemia. N Engl J Med 312:257–264

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Sandoz Ltd, Basle

About this paper

Cite this paper

Debusscher, L., Stryckmans, P. (1985). Ciclosporin for Therapy of Severe Aplastic Anemia (SAA) and Pure Red Cell Aplasia (PRCA). In: Schindler, R. (eds) Ciclosporin in Autoimmune Diseases. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70607-3_48

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70607-3_48

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-70609-7

  • Online ISBN: 978-3-642-70607-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics